Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion [2]

Archives of Ophthalmology

Volumn 120, Issue 9, 2002, Pages 1234-1236

  Kattah, Jorge C ^a   Wang, David Z ^a   Reddy, Chittaranjan ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; FIBRINOLYTIC THERAPY; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; LETTER; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PILOT PROJECTS; RECOMBINANT PROTEINS; RETINAL ARTERY; RETINAL ARTERY OCCLUSION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036736043     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Ocular neovascularization with retinal vascular occlusion. II: Occurrence in central and branch retinal artery occlusion
2. Efficacy of anterior chamber paracentesis and carbogen administration in treating acute, nonarteritic central retinal artery occlusion
3. Tissue plasminogen activator for acute ischemic stroke
4. Microcatheter urokinase infusion in central retinal artery occlusion
5. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion
6. Treatment of retinal artery occlusion with local fibrinolysis using recombinant tissue plasminogen activator
7. Indications for fibrinolyric therapy in suspected myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
8. Intracerebral hemorrhage after systemic thrombolysis in patients with occlusion of the central retinal artery: Report of 2 cases